Macrogenics Inc (MGNX) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Macrogenics Inc   (NASDAQ: MGNX)


Macrogenics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Macrogenics Inc 's ROA in the second quarter of 2026?
Macrogenics Inc recorded a cumulative net loss of $-15 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -5.48%.

However, within the Healthcare sector 261 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3615, from total ROA ranking in the first quarter of 2026 at 4280.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 40.74 % -2.98 % -4.52 % 11.08 % 38.39 %
Y / Y Net Income Change - - - -70.13 % -
Net Income (TTM) in million -15 -70 -75 -76 -36
Return On Assets (TTM) -5.48 % -29.14 % -30.69 % -30.86 % -15.22 %
MGNX's Total Ranking # 3615 # 4280 # 3777 # 3437 # 3709
Total Assets (TTM) in million 345 218 232 271 245
Seq. Total Assets Change 58.54 % -6.03 % -14.37 % 10.33 % 9.29 %
Seq. Net Income Change - - - - -

MGNX's 5 Years Annual ROA >> Back to MGNX Management Effectiveness >> Compare MGNX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 89
Sector # 262
Overall # 2973

Return On Assets Statistics
High Average Low
15.7 %
-27.47 %
-74.73 %
(Sep 30 2023)   (Sep 30 2022)



  News about Macrogenics Inc Return on Assets ROA

MacroGenics Faces Leadership Transition Amid Class Action Pressures as Shareholder Concerns Mount

MacroGenics Faces Leadership Transition Amid Class Action Pressures as Shareholder Concerns MountIn a significant development for the biopharmaceutical landscape, MacroGenics, Inc. (NASDAQ: MGNX), based in Rockville, Maryland, has announced a leadership transition that may set the stage for pivotal changes within the company. On October 30, 2024, the firm revealed that its President and Chief Executive Officer, Dr. Scott Koenig, M.D. Ph.D. intends to step down from his position early next year. This announcement comes at a time when the company is under scrutiny due to a pending class action lawsuit related to alleged financial misconduct, raising questions about its strategic direction and governance.To facilitate a seamless transition during this crucial period, MacroGenics’ Board of Directors has engaged the services of global executive search firm Heidrick and Struggles. The Board has also established a special committee dedicated to overseeing the CEO search process, underlining the urgency and significance of this leadership change. As the biopharmaceutical field rapidly evolves, the company s ability to identify a successor who can navigate both innovative therapeutic development and investor relations will be critical.



Financial Statements
Macrogenics Inc 's Assets $ 345 million MGNX's Balance sheet
Macrogenics Inc 's Income $ 20 million Quarterly MGNX's Income Statement
MGNX's Income by Division See MGNX's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -4.23 % -11.11 % 8.51 % -20.64 % -10.59 %
Total Assets in million 233 243 273 252 317
Y / Y Net Income Change - - - - -
Net Income in million -75 -67 -9 -120 -202
Annual Return On Assets -32.09 % -27.58 % -3.32 % -47.57 % -63.71 %

MGNX's 5 Years Annual ROA >> Back to MGNX Management Effectiveness >> Compare MGNX ROA to its Competitors



More Return On Assets Ratios
MGNX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MGNX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MGNX's Competitors
Subscribers only: Roa for Macrogenics Inc 's Suppliers
Subscribers only: Return On Assets for MGNX's Customers

You may also want to know
MGNX's Roi MGNX's Inventory Turnover Ratio MGNX's Growth Rates MGNX's Dividend Comparisons
MGNX's Profitability Ratios MGNX's Asset Turnover Ratio MGNX's Dividend Growth
MGNX's Roe MGNX's Valuation Ratios MGNX's Financial Strength Ratios MGNX's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-18T17:26:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.